RecruitingNot applicableNCT04078230
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
Studying Cholangiocarcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Second Affiliated Hospital, School of Medicine, Zhejiang University
- Intervention
- Extend LymphAdenectomy(procedure)
- Enrollment
- 168 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2020 – 2027
Study locations (13)
- The Johns Hopkins Hospital, Baltimore, Maryland, United States
- China-Japan Friendship Hospital, Beijing, Beijing Municipality, China
- Chinese PLA General Hospital, Beijing, Beijing Municipality, China
- Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China
- Hunan Provincial People's Hospital, Changsha, Hunan, China
- The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China
- Renji Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, Shanghai Municipality, China
- Xinhua Hospital Affiliated to Shanghai Jiao Tong University, Shanghai, Shanghai Municipality, China
- Zhong Shan Hospital Fudan University, Shanghai, Shanghai Municipality, China
- The First Affiliated Hospital of Xi 'an Jiaotong University, Xi’an, Shanxi, China
- West China Hospital Sichuan University, Chengdu, Sichuan, China
- The Second Affiliated Hospital Zhejiang University School of Medicine, Hanzhou, Zhejiang, China
- Zhejiang cancer hospital, Hanzhou, Zhejiang, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04078230 on ClinicalTrials.govOther trials for Cholangiocarcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07478523FAPI-PET Value for the Initial Screening of Pancreatic and Biliary CancersUniversity Hospital, Bordeaux
- RECRUITINGNANCT07476651Scout Dose of Resin MicrospheresSeoul National University Hospital
- RECRUITINGPHASE2NCT06728410A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or RearrangementMehmet Akce
- RECRUITINGPHASE2NCT07223307REGULUS: MRI-guided Adaptive SABR for Liver CancersStanford University
- RECRUITINGPHASE2NCT07201519Study of Safety/Feasibility of a Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion ChemotherapyMichael J Cavnar, MD
- RECRUITINGPHASE2NCT07260175Phase II Study Evaluating Ivosidenib Maintenance After SOC Adjuvant Chemotherapy in Curative mIDH1 CholangiocarcinomaInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- RECRUITINGNANCT06735560Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, ICC or NENNantes University Hospital
- RECRUITINGNANCT07263217Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver InjurySecond Affiliated Hospital, School of Medicine, Zhejiang University